AIDS defining conditions in Africans resident in the United Kingdom. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS defining conditions in Africans resident in the United Kingdom.

Int J STD AIDS. 1996 Jan-Feb;7(1):44-7. Unique Identifier : AIDSLINE MED/96228425
Del Amo J; Goh BT; Forster GE; Ambrose King Centre, Department of Genitourinary Medicine, Royal; London Hospital, Whitechapel, UK.

Abstract: A retrospective study of 55 HIV-1 seropositive African patients living in the UK, seen between January 1986 and November 1993, showed a total of 26 (47%) patients with AIDS. Thirty-one (56%) had symptomatic HIV disease at the time of presentation of whom 19 (34.5%) had an AIDS defining condition. Tuberculosis was the most common AIDS defining illness, accounting for 27% of all initial AIDS diagnoses, followed by by Pneumocystis carinii pneumonia and oesophageal candidiasis in 19% each and chronic mucocutaneous genital herpes in 15%. The mean CD4 count at the time of the first AIDS defining event was 91 x 10/mm3 (range 4-320 x 10/mm3). The profile of AIDS defining illnesses was different to published data of homosexual men and injecting drug users in the UK. This has practical implications when considering differential diagnoses and screening as well as prophylaxis for opportunistic infections in this group of patients.
Keywords: Acquired Immunodeficiency Syndrome/DRUG THERAPY/*ETHNOLOGY/ IMMUNOLOGY Adult Africa/ETHNOLOGY AIDS-Related Opportunistic Infections/DRUG THERAPY/*ETHNOLOGY/ IMMUNOLOGY CD4 Lymphocyte Count Female Human HIV Seropositivity/DRUG THERAPY/*ETHNOLOGY/IMMUNOLOGY *HIV-1 London/EPIDEMIOLOGY Male Middle Age Retrospective Studies JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/drugtherapy/KWDethnology/immunologyadultafrica/ethnologyaids-relatedopportunisticinfections/drugtherapy/KWDethnology/immunologycd4lymphocytecountfemalehumanhivseropositivity/drugtherapy/KWDethnology/immunologyKWDhiv-1london/epidemiologymalemiddleageretrospectivestudiesjournalarticle
961030
M96A1434

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .